References
- Society for Maternal-Fetal Medicine Publications Committee, Berkley E, Chauhan SP, et al. Doppler assessment of the fetus with intrauterine growth restriction. Am J Obstet Gynecol. 2012;206(4):300–308.
- Mahony R, McKeating A, Murphy T, et al. Appropriate antenatal corticosteroid use in women at risk for preterm birth before 34 weeks of gestation. BJOG. 2010;117(8):963–967.
- Potter SM, Dennedy MC, Morrison JJ. Corticosteroids and fetal vasculature: effects of hydrocortisone, dexamethasone and betamethasone on human umbilical artery. BJOG. 2002;109(10):1126–1131.
- Wallace EM, Baker LS. Effect of antenatal betamethasone administration on placental vascular resistance. Lancet. 1999;353(9162):1404–1407.
- Clifton VL, Wallace EM, Smith R. Short-term effects of glucocorticoids in the human fetal-placental circulation in vitro. J Clin Endocrinol Metab. 2002;87(6):2838–2842.
- Edwards A, Baker LS, Wallace EM. Changes in fetoplacental vessel flow velocity waveforms following maternal administration of betamethasone. Ultrasound Obstet Gynecol. 2002;20(3):240–244.
- Edwards A, Baker LS, Wallace EM. Changes in umbilical artery flow velocity waveforms following maternal administration of betamethasone. Placenta. 2003;24(1):12–16.
- Thuring A, Malcus P, Maršál K. Effect of maternal betamethasone on fetal and uteroplacental blood flow velocity waveforms. Ultrasound Obstet Gynecol. 2011;37(6):668–672.
- Ekin A, Gezer C, Solmaz U, et al. Effect of antenatal betamethasone administration on Doppler velocimetry of fetal and uteroplacental vessels: a prospective study. J Perinat Med. 2016;44(2):243–248.
- Chitrit Y, Caubel P, Herrero R, et al. Effects of maternal dexamethasone administration on fetal Doppler flow velocity waveforms. BJOG. 2000;107(4):501–507.
- Simchen MJ, Alkazaleh F, Adamson SL, et al. The fetal cardiovascular response to antenatal steroids in severe early-onset intrauterine growth restriction. Am J Obstet Gynecol. 2004;190(2):296–304.
- Hadlock FP, Harrist RB, Martinez-Poyer J. In utero analysis of fetal growth: a sonographic weight standard. Radiology. 1991;181(1):129–133.
- Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81(3):515–526.
- Walker BR, Williams BC. Corticosteroids and vascular tone: mapping the messenger maze. Clin Sci (Lond). 1992;82(6):597–605.
- Marinoni E, Korebrits C, Di Iorio R, et al. Effect of betamethasone in vivo on placental corticotropin-releasing hormone in human pregnancy. Am J Obstet Gynecol. 1998;178(4):770–778.
- Clifton VL, Read MA, Leitch IM, et al. Corticotropin-releasing hormone-induced vasodilatation in the human fetal placental circulation. J Clin Endocrinol Metab. 1994;79(2):666–669.
- Robertson MC, Murila F, Tong S, et al. Predicting perinatal outcome through changes in umbilical artery Doppler studies after antenatal corticosteroids in the growth-restricted fetus. Obstet Gynecol. 2009;113(3):636–640.